Practice-vs physician-level variation in use of active surveillance for men with low-risk prostate cancer: Implications for collaborative quality improvement

JAMA Surgery

Volumn 152, Issue 10, 2017, Pages 978-980

  Auffenberg, Gregory B ^a   Lane, Brian R ^b   Linsell, Susan ^a   Cher, Michael L ^c   Miller, David C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b SPECTRUM HEALTH   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER RISK; CLINICAL PRACTICE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; TOTAL QUALITY MANAGEMENT; UROLOGIST; AGED; COMMUNITY CARE; MICHIGAN; ORGANIZATION AND MANAGEMENT; PROSTATE TUMOR; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; UROLOGY;

AGED; COMMUNITY HEALTH SERVICES; HUMANS; MALE; MICHIGAN; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PROSTATIC NEOPLASMS; QUALITY IMPROVEMENT; REGRESSION ANALYSIS; UROLOGY;

EID: 85032647239     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2017.1586     Document Type: Letter

References (6)

1. Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990-2013. JAMA. 2015;314(1):80-82.
2. Loeb S, Folkvaljon Y, Curnyn C, Robinson D, Bratt O, Stattin P. Uptake of active surveillance for very-low-risk prostate cancer in Sweden [published online October 20, 2016]. JAMA Oncol. 2016. doi:10.1001/jamaoncol.2016.3600
3. Hoffman KE, Niu J, Shen Y, et al. Physician variation in management of low-risk prostate cancer: a population-based cohort study. JAMA Intern Med. 2014;174(9):1450-1459.
4. Womble PR, Montie JE, Ye Z, Linsell SM, Lane BR, Miller DC; Michigan Urological Surgery Improvement Collaborative. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. Eur Urol. 2015;67(1):44-50.
5. Cher ML, Dhir A, Auffenberg GB, et al; Michigan Urological Surgery Improvement Collaborative. Appropriateness criteria for active surveillance of prostate cancer. J Urol. 2017;197(1):67-74.
6. Mohler JL, Armstrong AJ, Bahnson RR, et al. Prostate cancer, version 1.2016. J Natl Compr Canc Netw. 2016;14(1):19-30.